Oncology Blood Testing Market
Description
Oncology Blood Testing Market: Global Industry Analysis 2017-2021 and Opportunity Assessment 2022-2032
A recent market study published by FMI on Oncology Blood Testing offers a global industry analysis for 2017-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
- By Application
- By Types
- By End User
- By Region
Executive Summary
The executive summary of the Oncology Blood Testing Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Oncology Blood Testing.
Chapter 01 - Market Overview
Readers can find the detailed segmentation and definition of the Oncology Blood Testing Market in this chapter, which will help to understand basic information about Oncology Blood Testing. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Oncology Blood Testing Market report.
Chapter 02 - Market Background
This chapter includes detailed analysis of the By Nature processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 - Global Oncology Blood Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032
The chapter include historical market value (US$ XX Billion) analysis (2017-2021) and current and future market value (US$ 47225.2 Million) and volume (15.2%) projections (2022-2032). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 - Global Oncology Blood Testing Market - Pricing Analysis
Based on By Nature, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 - Global Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Application
Based on By Application, Oncology Blood Testing Market is segmented into. This section also offers market attractiveness analysis based on By Application. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Application.
Chapter 06 - Global Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Type
Based on By Type, Oncology Blood Testing Market is segmented into. This section also offers market attractiveness analysis based on By Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Type.
Chapter 07 - Global Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End User
Based on By End User, Oncology Blood Testing Market is segmented into. This section also offers market attractiveness analysis based on By End User. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End User.
Chapter 08 - Global Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
Based on By Region, Oncology Blood Testing Market is segmented into North America,Latin America,Europe,East Asia,South Asia & Pacific,Middle East & Africa. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.
Chapter 09 - North America Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Oncology Blood Testing in the North American Region, along with a country-wise assessment that includes the US and Canada. Readers can also find Regional trends, regulations, and market growth based on different segment and countries in the North America Region.
Chapter 10 - Latin America Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Oncology Blood Testing in the Latin America Region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Oncology Blood Testing Market in the Latin America Region.
Chapter 11 - Europe Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Oncology Blood Testing in the European Region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Oncology Blood Testing Market in the Regional market.
Chapter 12 - East Asia Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Oncology Blood Testing in the East Asia Region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Oncology Blood Testing Market in the Regional market.
Chapter 13 - South Asia Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Oncology Blood Testing in the South Asia Region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Oncology Blood Testing Market in the Regional market.
Chapter 14 - Middle East and Africa Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Oncology Blood Testing in the MEA Region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Oncology Blood Testing Market in the Regional market.
Chapter 15 - Key Countries Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032
This chapter offers insights into how the Oncology Blood Testing Market is expected to grow in major countries globally.
Chapter 16 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 17 - Competition Deep Dive (Tentative List)
This chapter includes company overview, By Nature portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Guardant Health Inc., Trovagene Inc., Genomic Health Inc., Foundation Medicine Inc., Exosome Diagnostics, Pathway Genomics Corporation, F. Hoffman-La Roche Ltd., Abbott Laboratories, EntroGen Inc., Qiagen N.V., Cepheid, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Illumina Inc., CORE Diagnostics, Genoptix Inc., GenPath, NeoGenomics Laboratories Inc., Siemens, MolecularMD, ArcherDx Inc., ARUP Laboratories., Invivoscribe Inc., GenPath, Laboratory Corporation of America Holdings, Luminex Corporation, Myriad Genetics Inc., Roche Holding A.G., Invitae Corporation, Asuragen Inc., Molecularmd, EntroGen, Cepheid, Cancer Genetics, Adaptive Biotechnologies, Grail, Abingdon Health, Freenome, Vivia Biotech, Biofluidica, SkylineDX, Biodesix Inc., NovellusDX, BioNTech SE, etc.
Chapter 18 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Oncology Blood Testing report.
Chapter 19 - Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Oncology Blood Testing Market.
Table of Contents
342 Pages
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Investment Feasibility Matrix
- 3.5. PESTLE and Porter’s Analysis
- 3.6. Regulatory Landscape
- 3.6.1. By Key Regions
- 3.6.2. By Key Countries
- 3.7. Regional Parent Market Outlook
- 4. Global Oncology Blood Testing Market Analysis 2017-2021 and Forecast, 2022-2032
- 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
- 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Test Type
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Mn) Analysis By Test Type, 2017-2021
- 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test Type, 2022-2032
- 5.3.1. CBC (Complete Blood Count) Test
- 5.3.2. Blood Protein Test
- 5.3.3. Tumor Marker Test
- 5.3.4. CTC (Circulating Tumor Cells) – based Test
- 5.3.5. NIPT (Non-Invasive Prenatal Testing) Test
- 5.3.6. Liquid Biopsy Assays
- 5.3.7. Exom-Based Liquid Biopsy
- 5.4. Y-o-Y Growth Trend Analysis By Test Type, 2017-2021
- 5.5. Absolute $ Opportunity Analysis By Test Type, 2022-2032
- 6. Global Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Application
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
- 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
- 6.3.1. Lung Cancer
- 6.3.2. Breast Cancer
- 6.3.3. Colon Cancer
- 6.3.4. Melanoma
- 6.3.5. Ovarian Cancer
- 6.3.6. Gastro-Intestinal Stromal Tumor (GIST)
- 6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
- 6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
- 7. Global Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End User
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
- 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
- 7.3.1. Hospitals
- 7.3.2. Specialty Clinics
- 7.3.3. Diagnostic Laboratories
- 7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
- 7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
- 8. Global Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
- 8.1. Introduction
- 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
- 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
- 8.3.1. North America
- 8.3.2. Latin America
- 8.3.3. Europe
- 8.3.4. Asia Pacific
- 8.3.5. MEA
- 8.4. Market Attractiveness Analysis By Region
- 9. North America Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 9.2.1. By Country
- 9.2.1.1. US
- 9.2.1.2. Canada
- 9.2.2. By Test Type
- 9.2.3. By Application
- 9.2.4. By End User
- 9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Test Type
- 9.3.3. By Application
- 9.3.4. By End User
- 9.4. Key Takeaways
- 10. Latin America Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 10.2.1. By Country
- 10.2.1.1. Brazil
- 10.2.1.2. Mexico
- 10.2.1.3. Rest of Latin America
- 10.2.2. By Test Type
- 10.2.3. By Application
- 10.2.4. By End User
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Test Type
- 10.3.3. By Application
- 10.3.4. By End User
- 10.4. Key Takeaways
- 11. Europe Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 11.2.1. By Country
- 11.2.1.1. Germany
- 11.2.1.2. U.K.
- 11.2.1.3. France
- 11.2.1.4. Spain
- 11.2.1.5. Italy
- 11.2.1.6. Rest of Europe
- 11.2.2. By Test Type
- 11.2.3. By Application
- 11.2.4. By End User
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Test Type
- 11.3.3. By Application
- 11.3.4. By End User
- 11.4. Key Takeaways
- 12. Asia Pacific Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 12.2.1. By Country
- 12.2.1.1. China
- 12.2.1.2. Japan
- 12.2.1.3. South Korea
- 12.2.1.4. Rest of Asia Pacific
- 12.2.2. By Test Type
- 12.2.3. By Application
- 12.2.4. By End User
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Test Type
- 12.3.3. By Application
- 12.3.4. By End User
- 12.4. Key Takeaways
- 13. MEA Oncology Blood Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 13.2.1. By Country
- 13.2.1.1. GCC Countries
- 13.2.1.2. South Africa
- 13.2.1.3. Israel
- 13.2.1.4. Rest of MEA
- 13.2.2. By Test Type
- 13.2.3. By Application
- 13.2.4. By End User
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Test Type
- 13.3.3. By Application
- 13.3.4. By End User
- 13.4. Key Takeaways
- 14. Key Countries Oncology Blood Testing Market Analysis
- 14.1. US
- 14.1.1. Pricing Analysis
- 14.1.2. Market Share Analysis, 2021
- 14.1.2.1. By Test Type
- 14.1.2.2. By Application
- 14.1.2.3. By End User
- 14.2. Canada
- 14.2.1. Pricing Analysis
- 14.2.2. Market Share Analysis, 2021
- 14.2.2.1. By Test Type
- 14.2.2.2. By Application
- 14.2.2.3. By End User
- 14.3. Brazil
- 14.3.1. Pricing Analysis
- 14.3.2. Market Share Analysis, 2021
- 14.3.2.1. By Test Type
- 14.3.2.2. By Application
- 14.3.2.3. By End User
- 14.4. Mexico
- 14.4.1. Pricing Analysis
- 14.4.2. Market Share Analysis, 2021
- 14.4.2.1. By Test Type
- 14.4.2.2. By Application
- 14.4.2.3. By End User
- 14.5. Germany
- 14.5.1. Pricing Analysis
- 14.5.2. Market Share Analysis, 2021
- 14.5.2.1. By Test Type
- 14.5.2.2. By Application
- 14.5.2.3. By End User
- 14.6. U.K.
- 14.6.1. Pricing Analysis
- 14.6.2. Market Share Analysis, 2021
- 14.6.2.1. By Test Type
- 14.6.2.2. By Application
- 14.6.2.3. By End User
- 14.7. France
- 14.7.1. Pricing Analysis
- 14.7.2. Market Share Analysis, 2021
- 14.7.2.1. By Test Type
- 14.7.2.2. By Application
- 14.7.2.3. By End User
- 14.8. Spain
- 14.8.1. Pricing Analysis
- 14.8.2. Market Share Analysis, 2021
- 14.8.2.1. By Test Type
- 14.8.2.2. By Application
- 14.8.2.3. By End User
- 14.9. Italy
- 14.9.1. Pricing Analysis
- 14.9.2. Market Share Analysis, 2021
- 14.9.2.1. By Test Type
- 14.9.2.2. By Application
- 14.9.2.3. By End User
- 14.10. China
- 14.10.1. Pricing Analysis
- 14.10.2. Market Share Analysis, 2021
- 14.10.2.1. By Test Type
- 14.10.2.2. By Application
- 14.10.2.3. By End User
- 14.11. Japan
- 14.11.1. Pricing Analysis
- 14.11.2. Market Share Analysis, 2021
- 14.11.2.1. By Test Type
- 14.11.2.2. By Application
- 14.11.2.3. By End User
- 14.12. South Korea
- 14.12.1. Pricing Analysis
- 14.12.2. Market Share Analysis, 2021
- 14.12.2.1. By Test Type
- 14.12.2.2. By Application
- 14.12.2.3. By End User
- 14.13. GCC Countries
- 14.13.1. Pricing Analysis
- 14.13.2. Market Share Analysis, 2021
- 14.13.2.1. By Test Type
- 14.13.2.2. By Application
- 14.13.2.3. By End User
- 14.14. South Africa
- 14.14.1. Pricing Analysis
- 14.14.2. Market Share Analysis, 2021
- 14.14.2.1. By Test Type
- 14.14.2.2. By Application
- 14.14.2.3. By End User
- 14.15. Israel
- 14.15.1. Pricing Analysis
- 14.15.2. Market Share Analysis, 2021
- 14.15.2.1. By Test Type
- 14.15.2.2. By Application
- 14.15.2.3. By End User
- 15. Market Structure Analysis
- 15.1. Competition Dashboard
- 15.2. Competition Benchmarking
- 15.3. Market Share Analysis of Top Players
- 15.3.1. By Regional
- 15.3.2. By Test Type
- 15.3.3. By Application
- 15.3.4. By End User
- 16. Competition Analysis
- 16.1. Competition Deep Dive
- 16.1.1. Guardant Health Inc.
- 16.1.1.1. Overview
- 16.1.1.2. Product Portfolio
- 16.1.1.3. Profitability by Market Segments
- 16.1.1.4. Sales Footprint
- 16.1.1.5. Strategy Overview
- 16.1.1.5.1. Marketing Strategy
- 16.1.2. Multigen Diagnostics
- 16.1.2.1. Overview
- 16.1.2.2. Product Portfolio
- 16.1.2.3. Profitability by Market Segments
- 16.1.2.4. Sales Footprint
- 16.1.2.5. Strategy Overview
- 16.1.2.5.1. Marketing Strategy
- 16.1.3. Genomic Health Inc.
- 16.1.3.1. Overview
- 16.1.3.2. Product Portfolio
- 16.1.3.3. Profitability by Market Segments
- 16.1.3.4. Sales Footprint
- 16.1.3.5. Strategy Overview
- 16.1.3.5.1. Marketing Strategy
- 16.1.4. Foundation Medicine Inc.
- 16.1.4.1. Overview
- 16.1.4.2. Product Portfolio
- 16.1.4.3. Profitability by Market Segments
- 16.1.4.4. Sales Footprint
- 16.1.4.5. Strategy Overview
- 16.1.4.5.1. Marketing Strategy
- 16.1.5. Exosome Diagnostics
- 16.1.5.1. Overview
- 16.1.5.2. Product Portfolio
- 16.1.5.3. Profitability by Market Segments
- 16.1.5.4. Sales Footprint
- 16.1.5.5. Strategy Overview
- 16.1.5.5.1. Marketing Strategy
- 16.1.6. Roche
- 16.1.6.1. Overview
- 16.1.6.2. Product Portfolio
- 16.1.6.3. Profitability by Market Segments
- 16.1.6.4. Sales Footprint
- 16.1.6.5. Strategy Overview
- 16.1.6.5.1. Marketing Strategy
- 16.1.7. Bio-Techne
- 16.1.7.1. Overview
- 16.1.7.2. Product Portfolio
- 16.1.7.3. Profitability by Market Segments
- 16.1.7.4. Sales Footprint
- 16.1.7.5. Strategy Overview
- 16.1.7.5.1. Marketing Strategy
- 17. Assumptions & Acronyms Used
- 18. Research Methodology
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
